BET bromodomain protein inhibition reverses chimeric antigen receptor extinction and reinvigorates exhausted T cells in chronic lymphocytic leukemia-Reference-Cited by-同舟云学术

BET bromodomain protein inhibition reverses chimeric antigen receptor extinction and reinvigorates exhausted T cells in chronic lymphocytic leukemia

Published:2021-08-16 Issue:16 Volume:131 Page:
ISSN:1558-8238
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Kong Weimin,Dimitri Alexander,Wang Wenliang,Jung In-Young,Ott Christopher J.^ORCID,Fasolino Maria,Wang Yan,Kulikovskaya Irina^ORCID,Gupta Minnal^ORCID,Yoder Todd^ORCID,DeNizio Jamie E.,Everett John K.,Williams Erik F.,Xu Jun,Scholler John,Reich Tyler J.^ORCID,Bhoj Vijay G.,Haines Kathleen M.,Maus Marcela V.^ORCID,Melenhorst J. Joseph^ORCID,Young Regina M.,Jadlowsky Julie K.,Marcucci Katherine T.,Bradner James E.^ORCID,Levine Bruce L.^ORCID,Porter David L.^ORCID,Bushman Frederic D.,Kohli Rahul M.^ORCID,June Carl H.^ORCID,Davis Megan M.^ORCID,Lacey Simon F.^ORCID,Vahedi Golnaz,Fraietta Joseph A.^ORCID

Funder

Bob Levis Funding Group

National Institute of Allergy and Infectious Diseases

National Cancer Institute

National Institute on Aging

National Institute of General Medical Sciences

Penn Institute for Biomedical Informatics and Abramson Cancer Center

Gabrielle’s Angel Foundation for Cancer Research

Alliance for Cancer Gene Therapy

Novartis Pharmaceuticals Corporation

Publisher

American Society for Clinical Investigation